Search research articles
Contact Us
Filters
Showing results (81-90 of 336) with videos related to
Page
of 34
Sort By:
Anti-Cancer Drugs
|
February 1, 2007
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report
Sebastiano Buti, Matteo Riccò, Matteo Dalla Chiesa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 26, 2007
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC)
Sebastiano Buti, Matteo Brighenti, Cristiano Bongiovanni, et al.
Immunotherapy
|
September 22, 2018
Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literature
Sara Elena Rebuzzi, Giacomo Bregni, Massimiliano Grassi, et al.
Recenti Progressi in Medicina
|
December 20, 2018
[Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?]
Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 14, 2018
Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series
Alessandro Leonetti, Nunziata D'Abbiero, Giorgio Baldari, et al.
Immunotherapy
|
July 30, 2020
Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib
Luigi Cerbone, Sara Elena Rebuzzi, Elisabetta Lattanzi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 15, 2020
The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors
Fabiana Perrone, Roberta Minari, Melissa Bersanelli, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Katsuhiko Nara, Satoru Taguchi, Sebastiano Buti, et al.
La Radiologia Medica
|
May 10, 2020
Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT
Francesco Gentili, Ilaria Bronico, Umberto Maestroni, et al.
Expert Review of Anticancer Therapy
|
June 2, 2020
Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions
Maddalena Donini, Sebastiano Buti, Francesco Massari, et al.
Page
of 34
Search research articles
Search
Showing results (81-90 of 336) with videos related to
Sort By:
Page
of 34
Anti-Cancer Drugs
|
February 1, 2007
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report
Sebastiano Buti, Matteo Riccò, Matteo Dalla Chiesa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 26, 2007
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC)
Sebastiano Buti, Matteo Brighenti, Cristiano Bongiovanni, et al.
Immunotherapy
|
September 22, 2018
Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literature
Sara Elena Rebuzzi, Giacomo Bregni, Massimiliano Grassi, et al.
Recenti Progressi in Medicina
|
December 20, 2018
[Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?]
Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 14, 2018
Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series
Alessandro Leonetti, Nunziata D'Abbiero, Giorgio Baldari, et al.
Immunotherapy
|
July 30, 2020
Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib
Luigi Cerbone, Sara Elena Rebuzzi, Elisabetta Lattanzi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 15, 2020
The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors
Fabiana Perrone, Roberta Minari, Melissa Bersanelli, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Katsuhiko Nara, Satoru Taguchi, Sebastiano Buti, et al.
La Radiologia Medica
|
May 10, 2020
Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT
Francesco Gentili, Ilaria Bronico, Umberto Maestroni, et al.
Expert Review of Anticancer Therapy
|
June 2, 2020
Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions
Maddalena Donini, Sebastiano Buti, Francesco Massari, et al.
Page
of 34